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Meticillin-resistant Staphylococcus aureus (MRSA) is 
a major cause of healthcare-associated infections in 
Europe. Many examples have demonstrated that the 
spread of MRSA within healthcare settings can be 
reduced by targeted infection control measures. The 
aim of this systematic literature analysis and review 
was to summarise the evidence for the use of bacte-
rial cultures for active surveillance the benefit of rapid 
screening tests, as well as the use of decolonisation 
therapies and different types of isolation measures. 
We included 83 studies published between 2000 and 
2012. Although the studies reported good evidence 
supporting the role of active surveillance followed by 
decolonisation therapy, the effectiveness of single-
room isolation was mostly shown in non-controlled 
studies, which should inspire further research regard-
ing this issue. Overall, this review highlighted that 
when planning the implementation of preventive 
interventions, there is a need to consider the preva-
lence of MRSA, the incidence of infections, the com-
peting effect of standard control measures (e.g. hand 
hygiene) and the likelihood of transmission in the 
respective settings of implementation. 
Background
Meticillin-resistant Staphylococcus aureus (MRSA) 
is a major cause of healthcare-associated infections 
in Europe. In 2008, the European Centre for Disease 
Prevention and Control (ECDC) estimated that a total 
number of 171,200 nosocomial MRSA infections are 
acquired annually in the Member States of the European 
Union (EU), and in Iceland and Norway, resulting in 
5,400 attributable excess deaths, more than 1 million 
excess days of hospitalisation and EUR 380 million 
excess in-hospital costs [1]. The burden of MRSA infec-
tions was also shown in an analysis of data on health-
care-associated infections collected prospectively from 
European intensive care units (ICU) between 2005 and 
2008, where 1.7% of all patients developed S. aureus 
pneumonia or bloodstream infections. A mean of 35% 
of these infections were caused by MRSA. Moreover, 
the hazard ratio for mortality was 5.6-times higher 
(95% confidence interval (CI): 3.4–9.4) for patients 
with MRSA bloodstream infection than for patients 
without S. aureus bacteraemia [2].
Among the proposed methods to prevent MRSA, many 
(e.g. hand hygiene and transmission-based precau-
tions) have been used for general infection control, 
and their effectiveness has been reviewed extensively 
[3,4]. However, there is an ongoing discussion about 
the evidence for the effectiveness of several more spe-
cific prevention methods which, nevertheless, have 
been included in standards for the prevention and 
control of MRSA in a majority of European countries 
[5]. Therefore, the scope of this review was to analyse 
systematically recent literature (published after 2000) 
with respect to the following questions related to MRSA 
prevention and control:
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1. Does screening of patients before or on admission 
reduce the incidence of MRSA infection or transmis-
sion? How do PCR-based rapid tests for the direct 
detection of MRSA from screening specimens influ-
ence the incidence of MRSA colonisation or infec-
tion compared with culture-based methods?
2. Does the decolonisation of nasal MRSA or S. aureus 
carriage using mupirocin nasal ointment, alone or 
in combination with other agents, reduce colonisa-
tion or the development of infections?
3. Does isolation in single rooms of patients colonised 
or infected with MRSA prevent the spread of MRSA 
better than the use of transmission-based pre-
cautions (hand hygiene, gloves, aprons) alone? 
What is the effect of pre-emptive isolation of risk 
patients for MRSA carriage (until screening results 
are available)?
Methods
A systematic literature analysis and review was per-
formed following the Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA) 
guidelines [6]. To identify relevant publications, 
PubMed, EMBASE and Scopus were searched for arti-
cles published between 1 January 2000 and 31 October 
2012 in English language. The search terms were: 
MRSA AND (prevention OR control OR prophylaxis OR 
preventive measures OR preventive therapy OR preven-
tive treatment OR precaution OR screening OR active 
surveillance OR decolonization OR mupirocin OR sur-
veillance culture* OR chromogenic OR PCR OR poly-
merase chain reaction OR rapid test OR isolation OR 
hygiene OR efficien* OR effective*) AND (healthcare OR 
hospital OR nursing home OR long-term care facilit*); 
the search terms were adapted for search in EMBASE: 
“MRSA AND decolonization”, “MRSA AND isolation”, 
“MRSA AND screening”.
Titles and abstracts were screened independently by 
two reviewers (RK and AWF). Studies with outcomes 
measuring the incidence of MRSA colonisation or infec-
tion were included. Exclusion criteria were: Studies that 
did not report on the effects of the preventive meas-
ures on infection or transmission; studies performed in 
settings other than hospitals, long-term care facilities 
and nursing homes; case series, outbreak reports and 
Figure
Flow diagram for the selection of studies on preventive measures against to limit healthcare-associated infections by 
meticillin-resistant Staphylococcus aureus, published 2000–2012 (n=9,340)
9,340 records identified through database searching and screened
151 full -text articles assessedfor eligibility
83 or iginal articles included
A ssignment to one of the study 
questions
Screening IsolationD ecolonisation
82 articles excluded (outbreak 
reports, case series, reviews,
studies with outcome parameters 
not meeting inclusion crit eria)
9,189 records excluded


































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































reviews (the literature lists of the reviews were manu-
ally screened for additional relevant publications).
Data were extracted by AWF and RK independently 
using a standardised form. The study designs were 
assigned according to a modified study design scheme 
published by the Centre for Reviews and Dissemination 
at the University of York, United Kingdom, in the NHS 
economic evaluation database handbook from 2007. 
Formal assessment of the quality of studies was 
not performed. Due to the different study outcomes 
included, formal meta-analysis was considered inap-
propriate. Heterogeneity in methodology and outcome 
measures also prevented quantitative assessment of 
publication bias.
Results
The literature search identified 9,340 articles, 151 of 
which were retrieved as full texts after review of titles 
and abstracts. Of these, 69 articles fulfilled the criteria 
for inclusion and a further 14 articles were added after 
search through the literature lists of excluded review 
articles (Figure). Overall, 83 articles were included in 
the review [7-89].
Screening
We identified 41 studies that investigated the ques-
tion whether screening for MRSA carriers before or on 
admission had an impact on MRSA acquisition or infec-
tion rates (Table 1) [7-47].
Culture-based screening
Twenty-five studies used culture-based screening 
approaches, including two randomised controlled tri-
als (RCTs) and 23 comparative studies mostly using 
a before-and-after design [9,10,12,15,19-21,27,28,30-
38,40,42-47]. Of these 25 studies, seven used unspeci-
fied culture-based techniques [12,21,27,28,37,40,46], 
eight used MRSA chromogenic media (at least par-
tially) [19,31-34,38,45,47] and the others used mannitol 
salt, oxacillin salt or blood agars. An estimate for the 
turnaround times (TAT) of screening results was only 
reported in eight of the 25 studies (1 d–5.2 d) [10,12,19-
21,33,34,38]. Overall, 19 of the 23 comparative studies 
included reported trends of decreasing rates of MRSA 
infection or colonisation [10,12,15,19,21,27,28,30-
32,35-38,40,42,43,45,46], two reported ambiguous 
results [44,47], and two reported no reduction of MRSA 
infections or transmission [33,34]. The two RCTs found 
no reduction of MRSA infections or transmission [9,20].
PCR-based screening
Sixteen studies used PCR-based screening techniques 
in their intervention phases, including one RCT, two 
prospective cohort studies and 13 comparative stud-
ies [7,8,11,13,14,16-18,22-26,29,39,41]. The TAT of the 
PCR screening result was reported in 11 of 16 studies 
(0.67 d–1.5 d) [7,11,13,14,16-18,23,25,26,29]. Overall, 
seven of 16 studies documented positive effects on the 
occurrence of MRSA infections or transmissions after 
implementation of screening [8,11,14,18,24,26,29]. 
One study reported ambiguous results [16]. Among the 
studies reporting a decrease of infection or transmis-
sion, five compared the intervention group (PCR-based 
screening) to a control group without active surveil-
lance, with non-compulsory active surveillance or 
with screening of limited risk groups [8,11,24,26,29], 
and two compared with a control group where routine 
culture-based screening was performed [14,18]. Among 
the eight studies which could not document decreasing 
trends in MRSA infections or transmission following 
the implementation of screening, three compared PCR-
based screening with culture-based screening [7,13,23], 
four compared the intervention to control periods with-
out any active surveillance of MRSA [17,22,39,41], and 
one compared the intervention with a baseline period 
where PCR-based screening of selected risk patients 
was performed [25].
Screening (PCR-based and culture-based) vs no 
screening stratified by outcome measure
In eight of nine studies (89%) using this outcome param-
eter, MRSA bacteraemia rates decreased after imple-
mentation of screening [8,11,21,26,28,31,32,38,47]. 
Incidence of MRSA acquisition or transmission 
decreased in three of eight studies (38%) assessing 
this outcome parameter [8,9,17,32-34,43,44]. Three of 
five studies (60%) using wound infection and surgical-
site infections (SSI) as an outcome parameter showed 
decreasing SSI rates after implementation of screening 
[8,17,24,37,39]. A decrease of MRSA was observed in 
20 of 23 studies (87%) using all or unspecified MRSA 
infections or cases of colonisation/infection as their 
outcome parameters [8-10,12,15-17,19,20,22,25-27, 
29,30,35,36,40-42,45-47]; among these studies, one 
found a decrease only in medical ICUs [16].
PCR-based vs culture-based screening
Five investigations compared PCR-based to culture-
based screening [7,13,14,18,23]. All five documented 
that the TAT was reduced when compared to culture-
based approaches (Table 1). However, three studies 
found no difference in MRSA acquisition or infection 
rates [7,13,23]. In contrast, one before-and-after study 
found a reduction in the incidence of MRSA transmis-
sion after introduction of the PCR-based test which 
almost reached statistical significance, and one cohort 
study reported a reduction in MRSA acquisition rates 
[14,18].
Decolonisation
A total of 11 RCTs, 23 comparative studies and one pro-
spective cohort study evaluated the effectiveness of 
mupirocin-based nasal decontamination regimens for 
the prevention of S. aureus infections (Table 2) [48-82]. 
Of all 11 RCTs, six demonstrated significantly decreas-
ing infection trends after implementation of decoloni-
sation [48,51,52,72,73,75]; for one of these, this was 
only observed when selective digestive decontamina-
tion was added to nasal decolonisation [52], and for 
one RCT, the effect was only analysed for Gram-positive 
infections (which were mostly MRSA) [75]. Stratified by 
34 www.eurosurveillance.org
types on infections prevented, the RCTs showed that 
decolonisation decreased deep S. aureus SSI [48], 
overall S. aureus infections [48,51,73], overall infection 
rates [52], Gram-positive pneumonia [75] and S. aureus 
exit-site infections [72].
Among the 24 non-randomised studies identified, 
19 reported evidence that the use of mupirocin was 
effective in reducing infection. Of the seven studies 
performed in ICUs, six (86%) demonstrated an effect; 
specifically, a decrease in pneumonia and hospital-
acquired S. aureus infection [59], in the overall infec-
tion rates in ICUs [50,70], in MRSA SSI and bloodstream 
infections (BSI) in ICUs [55], and in the overall number 
of MRSA infections in ICUs [80,81]. Non-controlled 
studies implementing decolonisation in non-ICU set-
tings led to a decrease in overall and peristomal MRSA 
infections [57,76], in the incidence of S.aureus/MRSA 
SSI in surgical units [55,58,64,65,71,77,79], in overall 
S. aureus/MRSA infections in gastrointestinal surgery 
and orthopaedics [49,82], and in the total rate of SSI or 
wound infections [53,60,67].
Stratified by different implementation settings, four of 
five studies documented success among patients under-
going cardiothoracic surgery [53,65,66,71,77], four of 
six in orthopaedic departments [49,60,61,63,64,79], 
and six of seven in other or mixed surgical departments 
[54,55,58,67,73,75,82]. Moreover, seven of eight studies 
performed in ICU settings [50,52,55,59,68,70,80,81], 
two of two performed in haemodialysis units [51,72], 
two of five performed in different non-surgical depart-
ments [56,57,69,76,78], and one of three studies per-
formed hospital-wide or in both medical and surgical 
departments [48,62,74], demonstrated successful 
effects of mupirocin-treatment.
Stratified by different causative organisms, eight stud-
ies showed that mupirocin-treatment led to a decrease 
in the overall incidence of infections due to all organ-
isms [49,53,60,64,65,67,70,77]. In the same studies, 
this effect was partially non-significant for S. aureus/
MRSA infections in particular [53,60,67,70]. Four stud-
ies reported a decrease in infections caused by methi-
cillin-sensitive S. aureus (MSSA) [48,51,55,65]. Twelve 
investigations revealed a reduction in MRSA infections 
[49,50,55,57,58,64,76,77,79-82], six showed decreas-
ing trends for S. aureus (MRSA and/or MSSA) infec-
tions [50,59,71-73,82] and one reported reduction of 
pneumonia caused by Gram-positive bacteria (mostly 
MRSA) [75].
Many of the studies identified in this review used 
mupirocin-only regimens [51,55,59,60,63,67,70-
73,75,78,82]. Others combined nasal mupirocin with 
other topical agents to support decolonisation, includ-
ing chlorhexidine [48,50,53,56-58,61,62,64-68,74,81], 
triclosan [49,76,79], extra-nasal use of mupirocin 
[69,77,80], selective digestive decontamination [52], 
povidone-iodine [49], and systemic antibiotics [54].
Isolation
Focusing on the physical isolation of patients in sepa-
rate single or cohort rooms, we identified one cohort 
study and seven comparative studies reporting on the 
effectiveness of this measure (Table 3) [16,83-89]. Five 
studies were performed in ICU settings [16,83-85,88], 
one in a vascular surgery ward, one in a diabetic food 
unit, and one hospital-wide [86,87,89]. In two of these 
studies, nurse cohorting was performed in addition 
to single-room isolation [83,86]. Overall, one cohort 
and three comparative studies reported on benefi-
cial effects of single-room isolation (not performed 
pre-emptively) on MRSA colonisation or infection 
[85,86,88] and on acquisition rates [84]. Two compara-
tive studies did not find a reduction of transmission 
[83] or MRSA prevalence [87].
Three studies assessed the role of pre-emptive iso-
lation measures pending the results of screening 
[16,86,89]. In one before-and-after study, pre-emptive 
isolation precautions led to a reduction of the MRSA 
acquisition rate (0.21% vs 0.07%; p=0.04) [89]. In a 
retrospective comparative study placing all admit-
ted patients in pre-emptive isolation, the number of 
nosocomial MRSA isolates was reduced (p=0.005). 
However, simultaneous introduction of a cohort isola-
tion facility with dedicated staff makes the effects of 
this measure indistinguishable from the effects of pre-
emptive isolation [86]. The third was a study that eval-
uated the effects of simultaneous implementation of 
pre-emptive isolation and a rapid screening test on the 
incidence of MRSA infections in two ICUs [16] resulting 
in a significant reduction of ICU-acquired infections in 
a medical but not in a surgical ICU.
Discussion
Improving the rational use of antibiotics and the imple-
mentation of hand hygiene are clearly cornerstones 
of MRSA prevention and control [90-92]. Moreover, 
benchmarking and public reporting systems have 
recently been demonstrated to successfully support 
infection control measures [93]. However, the effec-
tiveness of screening, decolonisation and isolation for 
MRSA prevention when implemented routinely in set-
tings with endemic MRSA, remains controversial. For 
example, it is debated to what extent microbiological, 
strain-specific factors have contributed to the decreas-
ing MRSA trends [94,95]. Therefore, the present review 
aimed to focus on three important measures and to 
summarise the current evidence for their impact on 
MRSA prevention.
Screening
The strategy of screening is based on the finding that 
microbiological cultures performed for clinical reasons 
fail to detect previously unknown MRSA carriers at 
admission in 69 to 85% of patients [96,97]. Technically, 
screening can be performed by culture-based methods 
(screening swab streaked onto non-selective or chro-






























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Screening vs no screening
Of 36 cohort and comparative studies investigating the 
effectiveness of compulsory screening compared with 
no or non-compulsory screening, 27 reported decreas-
ing trends in the rates of MRSA infection or acquisition; 
this is in accordance with a meta-analysis describing 
a decrease in MRSA bloodstream infections (relative 
risk (RR): 0.54; 95% CI: 0.41–0.71) and surgical site 
infections (RR: 0.69; 95% CI: 0.46–1.01) [98]. On the 
other hand, two RCTs found that MRSA acquisition or 
infection in the intervention groups did not differ sig-
nificantly from the control groups [9,20]. However, in 
both studies, the median time for reporting a positive 
screening result was very long (3 days and 5.2±1.4 
days), which led to delayed implementation of con-
tact precautions. In addition, compliance with trans-
mission-based precautions was not as required [20] 
and the prevalence of MRSA infection was low in one 
of the studies [9]. Comparing successful and unsuc-
cessful interventions, we did not find clear differences 
between the studies regarding the specimens used for 
screening (nasal swab only vs other swabs in addition) 
or the patient population included (all patients admit-
ted vs high-risk patients only).
There was a tendency that studies including ‘inci-
dence of MRSA acquisition’ as an outcome parameter, 
reported a success less frequently (three of eight stud-
ies) compared with studies focusing on MRSA infec-
tion rates using the outcome parameters ‘occurrence 
of bacteraemia’ (eight of nine studies) or ‘SSI’ (three of 
five studies). The reason for this effect is not known, 
but it could highlight that screening does not necessar-
ily affect the rate of cross-transmission on the ward, 
unless it is linked to additional preventive measures; 
decolonisation, for instance, was not performed in two 
of the the studies measuring incidence of acquisition 
[33,34], while in two others, single-room isolation was 
omitted or only performed if available [9,17].
                                                
In conclusion, we found evidence that screening can 
help decrease MRSA infection rates in hospitals. This 
is also supported by macro-epidemiological data and 
mathematical models showing that without screen-
ing, other infection control measures might fail to 
effectively reduce MRSA spread [99-102]. However, 
the included RCTs did not confirm the findings of non-
controlled studies. This makes it impossible to firmly 
recommend the implementation of screening in all set-
tings. However, the evidence provided can support the 
introduction of a programme for active surveillance of 
MRSA in settings that have hyperendemic MRSA cross-
infections in spite of a high level of compliance with 
standard precautions. Clearly, the implementation of 
screening needs to be linked to other targeted infec-
tion control measures (e.g. hand hygiene) to achieve 
optimal impact.
Culture-based screening vs PCR-based screening
Screening for MRSA colonisation of patients at admis-
































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































72 hours until the results are available on the wards 
[103,104]. During this time MRSA can spread among 
inpatients. Therefore, various PCR-based methods 
have been developed to reduce the TAT [105,106]. 
Reduction of TAT was indeed confirmed by all studies 
on PCR-based tests identified in this review. But these 
studies mostly did not find a significant reduction of 
MRSA infection or acquisition rates. These results are 
in accordance with data from a meta-analysis showing 
that, compared with cultures, the use of rapid tests 
was not associated with a significant decrease in MRSA 
acquisition rates (risk ratio 0.87; 95% CI: 0.61–1.24) 
[98]. On the other hand, we found two studies report-
ing on a significant reduction of MRSA acquisition and 
a trend towards declining transmission [14,18]. They 
demonstrate that implementation of PCR-based sur-
veillance can be beneficial at least in facilities where 
culture results have a very long TAT (>3 days) [14,18].
We conclude that in settings where MRSA screening 
based on cultures, followed by the implementation of 
additional precautions, is already implemented, the 
current evidence does not suggest replacing or supple-
menting culture-based surveillance with rapid tests. 
However, besides accelerating the implementation of 
additional precautions, the high negative predictive 
value of MRSA rapid tests may also be useful when dis-
continuing contact precautions (including single-room 
isolation) in settings where they are implemented pre-
emptively for suspected MRSA carriers [103]. However, 
the reliability of a negative nasal rapid test has not 
been evaluated in situations where pre-emptive iso-
lation is performed for high-risk patients, who are 
often carrying MRSA at extranasal sites (e.g. wounds). 
Furthermore, using rapid tests in low prevalence set-
tings may increase the number of false-positive tests 
(positive predictive values: 31–78%) [103,107-110].
Decolonisation
The effectiveness of mupirocin nasal ointment to 
eradicate MRSA has been estimated to be 94% one 
week after treatment and 65% after a 14-day follow-
up period [111,112]. Effectiveness of MRSA decolonisa-
tion therapy is obviously limited when extranasal sites 
are colonised [113]. Since nasal carriage of S. aureus 
is a major risk factor for subsequent nosocomial infec-
tion, there is a theoretical rationale that eradicating S. 
aureus from the nares can reduce the development of 
infection. It is, however, controversial to what extent 
studies assessing the effectiveness of decolonisa-
tion among patients carrying MSSA also hold les-
sons for MRSA [114]. In this review, we have identified 
only four studies in which mupirocin-treatment was 
not restricted to MRSA carriers and where effects on 
MRSA and MSSA infections were reported separately. 
All four documented a decrease in MRSA, but found 
insignificant results for MSSA [64,77,79,82]. However, 
this does not mean that mupirocin-based decolonisa-
tion is ineffective against MSSA in general, since two 
randomised trials have reported a reduction of MSSA 






























































































































































































































































































































































































































































































































































































unknown, and the question whether results obtained 
for MSSA can be transferred to MRSA is unresolved. 
Despite potential local differences in mupirocin sus-
ceptibility and the occurrence of clonal lineages [114], a 
plausible biological explanation why results on MSSA 
decolonisation treatment should not be applied for 
MRSA, is currently lacking. Therefore, we have explic-
itly included studies dealing with S. aureus decoloni-
sation. However, future studies will have to assess in 
detail the differences between the preventive effec-
tiveness of MSSA and MRSA decolonisation.
Regarding the setting of implementation, we found 
that 14 of 18 studies carried out mostly in surgical 
settings have found a reduction in infection rates, 
whereas six of 10 studies which did not report effec-
tiveness, were performed mostly in non-surgical set-
tings [56,62,68,69,74,78]. However, preventive effects 
have been documented for non-surgical patients, e.g. 
in haemodialysis units, ICUs or in gastroenterology [50
,51,55,57,59,68,70,72,76,81].
Overall, we conclude that, taking into account local 
rates of healthcare-associated infections and infection 
control conditions, mupirocin-based decolonisation 
therapy should be considered for selected S. aureus 
carriers who are at high risk of developing nosocomial 
S. aureus infections. The best evidence is available 
for patients undergoing cardiothoracic or orthopaedic 
surgery. Of note, the preventive use of mupirocin for 
decolonisation is constrained by the development of 
resistance, found in 1% of all subjects when mupirocin 
was used for short-term prophylaxis. Increasing low-
level mupirocin resistance (8–256 µg/mL) has recently 
been reported in parallel to increased mupirocin con-
sumption [112,115,116].
Isolation
There are multiple approaches to organise isolation 
measures: Patients can be transferred to special isola-
tion wards, housed in nursing cohorts with designated 
staff, isolated in single or cohort rooms on general 
wards without designated personnel, or housed in the 
same room as patients not affected by MRSA while 
applying barrier precautions (e.g. gloves and gowns) 
when caring for the MRSA patient. In this review, we 
focussed on single room or cohort room isolation 
because this measure is sometimes debated as it can 
be associated with disadvantages for the isolated 
patient [117]. Moreover, in settings with a high preva-
lence of MRSA, isolation of patients may be hindered 
due to insufficient side room capacity and financial 
constraints, if isolation results in bed-blocking.
Overall, we found four studies showing that single 
room isolation led to a reduction in nosocomial MRSA 
acquisition and in the incidence of MRSA infection [84-
86,88]. In contrast, in a prospective interrupted-time-
series study it was found that, MRSA acquisition was 
not different in phases during which MRSA-colonised 
or infected patients were moved to single or cohort 
isolation, compared with phases during which they 
were not moved [83]. However, limitations of this study 
are delayed notification of screening results, a high 
number of missed screenings (80–87% of patients 
at admission and 71–75% at discharge) and low com-
pliance with hand hygiene (21% compliance) [83]. 
Moreover, a retrospective comparative study showed 
that discontinuing single-room isolation and applying 
transmission-based precautions (e.g. masks, gowns, 
gloves) for MRSA patients did not lead to an increase 
in the prevalence of MRSA. However, that study did not 
measure the occurrence of transmission on the wards 
and the incidence of MRSA infections [87].
We conclude that the limited evidence from non-con-
trolled studies which is available to support the use of 
single-room isolation for MRSA (outside of outbreaks) 
should inspire further research in this field to facilitate 
the development of evidence-based guidance in future, 
also for the prevention and control of other multidrug-
resistant organisms. However, the majority of studies 
identified and observations made during outbreaks 
support the use of single-rooms [3]. Therefore, where 
facilities (isolation wards, single rooms, cohort rooms) 
for the isolation of MRSA patients are available, their 
use should be recommended.
In all investigations identified, it is difficult to estimate 
to what extent the observed preventive effects were 
attributable to pre-emptive isolation or to other meas-
ures implemented in parallel [16,86,89]. Consequently, 
there is a need to assess the evidence for the use of 
pre-emptive isolation measures in hospitals. This 
is of major importance, because authors evaluating 
PCR-based screening tests often suggested that rapid 
tests could accelerate the start of isolation precautions 
[16,103,118]. However, these advantages cannot be 
assessed adequately as long as the additional value of 
pre-emptive isolation is unclear.
Conclusion
We have documented that the evidence for the effec-
tiveness of three major MRSA prevention and control 
measures does not allow for clear guidance offering 
‘one-size-fits-all’ solutions, because the effective-
ness of these interventions seems highly depending 
on the prevalence of MRSA, compliance with general 
infection control measures (e.g. hand hygiene), the 
incidence and type of infections and the transmis-
sion rates within the respective setting of implemen-
tation. This is documented by the ambiguous study 
results presented here. In addition, models on the 
effectiveness of MRSA prevention strategies in differ-
ent settings have shown that even measures which are 
performed highly effectively in outbreaks or low-prev-
alence areas, failed to control MRSA when applied for 
long-term control or in high-prevalence settings [119]. 
These difficulties have led to the development of mod-
els describing the effects and costs associated with 
universal vs selective MRSA screening in different set-
tings, which may facilitate the implementation of local 
45www.eurosurveillance.org
standards [104,120]. Moreover, some authors have 
recently described the effectiveness of several preven-
tive bundles comprising the measures reviewed here in 
combination with other interventions. For example, it 
was shown that universal nasal screening, contact pre-
cautions for patients colonised or infected with MRSA, 
hand hygiene, and changes in the institutional culture 
of responsibility reduced MRSA infections by 62% [99]. 
Others have identified that structural factors such as 
engaging front-line staff, building multidisciplinary 
teams, providing monitoring and feedback, and acquir-
ing management support were key measures for the 
success of MRSA prevention [121]. The evaluation of 
such bundles with respect to their effects, feasibility 
and applicability in different healthcare systems (e.g. 
different countries), clinical departments and patient 
collectives could in the future guide preventive efforts. 
Compared to assessing the effects of single preventive 
measures separately (as done in this review), the main 
advantage of assessing the effects of bundles is that 
they are planned specifically for targeted healthcare 
sectors, and the assessment can take into account the 
financial and other structural conditions in the respec-
tive settings.
In this review, we did not restrict the eligibility crite-
ria to controlled studies such as RCTs, although quasi-
experimental study designs are prone to be associated 
with various biases (e.g. selection bias or size of study 
population). This was done because only very few con-
trolled investigations have been published. In addi-
tion, among the 14 RCTs included, most of which were 
performed for assessing the effectiveness of decoloni-
sation therapy, a majority did either include patients 
affected by MSSA or did not stratify their outcomes for 
MSSA and MRSA infections. This makes the results, 
even of these formally ‘high-quality’ studies, disput-
able. Against this background, we decided not to per-
form a formal grading of the quality of the included 
studies, but rather to present the study results holisti-
cally and leave their use in various settings and coun-
tries open for interpretation.
The controversy about different implementation path-
ways for screening, isolation and decolonisation 
should not obscure the fact that the beneficial effects 
of MRSA control measures in general [120] support the 
recommendations made in many European national 
MRSA policies from low prevalence countries (e.g. the 
Nordic countries and the Netherlands) and high preva-
lence countries (e.g. France, Germany, and the United 
Kingdom), where a combination of these measures are 
the standard of care and a reduction in MRSA infections 
has recently been achieved by coordinated efforts even 
in high prevalence settings [5,122]. 
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